Borst, Jannie
Leiden University Medical Center · Oncode Institute
7 papers on CoChatORCID 0000-0002-8043-5009
Most cited papers
- Verified
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology
Immunotherapy and Immune ResponsesT-cell and B-cell Immunology
Cited by 1,585
- Verified
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Mezzadra, R., Sun, C., Jae, L. T., Gomez-Eerland, R., de Vries, E., Wu, W., Logtenberg, M. E. W., Slagter, M., Rozeman, E. A., Hofland, I., et al. (2017) · Nature
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 697
- Verified
CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets
Ribot, J. C., deBarros, A., Pang, D. J., Neves, J. F., Peperzak, V., Roberts, S. J., Girardi, M., Borst, J., Hayday, A. C., Pennington, D. J., et al. (2009) · Nature Immunology
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 628
- Verified
CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples
Mason, D., Cordell, J., Brown, M., Borst, J., Jones, M., Pulford, K., Jaffe, E., Ralfkiaer, E., Dallenbach, F., & Stein, H. (1995) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 193
- Verified
Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity
Cuadrado, E., van den Biggelaar, M., de Kivit, S., Chen, Y.-Y., Slot, M., Doubal, I., Meijer, A., van Lier, R. A. W., Borst, J., & Amsen, D. (2018) · Immunity
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 132
- Verified
Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC
Oja, A. E., Piet, B., van der Zwan, D., Blaauwgeers, H., Mensink, M., de Kivit, S., Borst, J., Nolte, M. A., van Lier, R. A. W., Stark, R., et al. (2018) · Frontiers in Immunology
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 130
- Verified
Opportunities for Small Molecules in Cancer Immunotherapy
van der Zanden, S. Y., Luimstra, J. J., Neefjes, J., Borst, J., & Ovaa, H. (2020) · Trends in Immunology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 119
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free